Original fundamental research starts and ENDS here.
Sectors Tags Blog
MDT
8 filings
Timeline Columns Start Research 8-K Categories
Showing: Earnings Clear filter
2025
Q4 1 filings
Nov
Q2 FY2026 Earnings
Second quarter fiscal year 2026 financial results announced
8-K
Q3 1 filings
Aug
Q1 Earnings + Board Expansion
Q1 FY2026 results; Board expanded from 11 to 13 directors
8-K
Q2 1 filings
May
Q4 Earnings & Diabetes Spinoff
FY2025 results announced, Diabetes business separation into standalone public company
8-K
Q1 1 filings
Feb
Q3 FY2025 Earnings
Third quarter fiscal year 2025 financial results announced
8-K
2024
Q4 1 filings
Nov
Q2 FY2025 Earnings
Second quarter fiscal year 2025 financial results announced
8-K
Q3 1 filings
Aug
Q1 FY2025 Earnings
First quarter fiscal year 2025 financial results
8-K
Q2 1 filings
May
Q4 and Full Year FY2024 Earnings
Full year and fourth quarter fiscal year 2024 financial results announced
8-K
Q1 1 filings
Feb
Q3 Earnings & Executive Departure
Q3 FY2024 results + Robert J. White departing April 26
8-K
SECENDS is not affiliated with the SEC. Data from public EDGAR filings. Not financial advice.